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INTRODUCTION
Solitary plasmacytoma is a monoclonal plasma cell malignancy that consists of one lesion with no other systemic symptoms (hypercalcemia, anemia, kidney dysfunction). The incidence rate of plasmacytoma is 3-5% from all plasma cell malignancies with a higher frequency in males (65%). The age median in the onset of diagnosis is 55 years. Solitary plasmacytoma can progress to Multiple Myeloma (MM) in 50% of cases. The time 1 median of progression into MM is 19 months. A case about plasmacytoma progressing rapidly to MM within two months from the initial diagnosis is hereby described.
CASE
A 45-year-old male attended the Surgery Outpatient Clinic with a chief complaint of progressive swelling on the left neck for two months. In the beginning, the mass was the size of a marble. It was painless and no disturbance in swelling. The patient was planned for further examinations, but he did not follow the instruction. Two months later he returned with the main complaint of fatigue.
Physical examination of the patient showed a solitary solid mass, 8cm in diameter, regular borders and not mobile on the left supraclavicular (Figure 1 and gamma (5) examination was done in November 2017, which concluded a high-grade plasmacytoma (Figure 2 ). On his second visit, he developed anemia. The complete blood count examination is presented in Table 1 . Bone marrow aspiration was done with the conclusion of multiple myeloma (Figure 3 ). The proportion of plasma cells in the bone marrow was 78% (Table 2 ). Serum electrophoresis protein was done with the result of a monoclonal spike in the beta region.
DISCUSSION
Solitary plasmacytoma is an accumulation of monoclonal neoplastic plasma cells without systemic 1 involvement. The plasmacytoma incidence on clavicula is infrequent, 0.45% of all primarybone tumors. Transformation into MM can be found in 3 50% of solitary plasmacytoma. Solitary plasmacytoma has a better prognosis than multiple myeloma, thus, early and accurate diagnosis of MM is essential in solitary plasmacytoma management.
Solitary plasmacytoma diagnosis, in this case,was based on biopsy result, no anemia, hypercalcemia, kidney disorder, systemic bone lesion, and less than transmembrane dimer protein expressed on B cells 8 and can serve as a B cell marker. Syndecan-1 (CD138) in the hematopoietic system is only found in plasma 9 cells and can be a specific marker for plasma cells. The immunohistochemistry result of this case was CD 20 negative, CD 79a positive and CD 138 positive which supported the diagnosis of plasmacytoma.
Ki 67 is anuclear protein which is related to cell proliferation and can reflect tumor burden. This protein is only expressed by actively proliferating 10, 11 cells. Ki 67 result was very high in this case (80% of cell tumors). The cell showed the high activity of cell 10 proliferation (high-grade tumor).
The diagnosis of MM was based on bone marrow examination (Table 2) , which result was plasma cell proportion of 78% (a myeloma defining event) with anemia symptom, bone lesion, and monoclonal 
CONCLUSION
Solitary plasmacytoma can progress rapidly into MM, which needs to be proven by laboratory examination and bone marrow aspiration. Early evaluation of MM systemic symptoms is very important for plasmacytoma case management.
